Hyperfine Inc
HYPR
View Detailed Chart
1.100USD
+0.060+5.77%
Close 02/06, 16:00（ET）Quotes delayed by 15 min
88.53MMarket Cap
LossP/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
+5.77%
5 Days
-1.79%
1 Month
+7.84%
6 Months
-5.98%
Year to Date
+12.33%
1 Year
-35.67%
View Detailed Chart
TradingKey Stock Score of Hyperfine Inc
Currency: USD Updated: 2026-02-06Key Insights
Hyperfine Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 106 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 1.65.In the medium term, the stock price is expected to remain stable.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Hyperfine Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Hyperfine Inc Highlights
StrengthsRisks
Hyperfine, Inc. is a health technology company. The Company is engaged in providing patient care globally through artificial intelligence (AI)-powered portable ultra-low-field (ULF) magnetic resonance (MR) brain imaging. Its Swoop Portable MR Imaging System (Swoop system) produces images at a lower magnetic field strength than conventional magnetic resonance imaging (MRI) scanners. Its Swoop system is designed to transform brain MR for the patient, the clinician and the provider, enabling a highly differentiated experience for patients, timely imaging for clinicians, and favorable economics for hospital administrators. The Swoop system is a portable ULF MRI device for producing images that display the internal structures of the head where full diagnostic examination is not clinically practical. The Swoop system is FDA-cleared for brain imaging of patients of all ages. The Swoop system is commercially available in a select number of international markets.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 89.17% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 12.89M.
Undervalued
The company’s latest PE is -2.10, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 9.49M shares, decreasing 13.21% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 47.10K shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.38.
Analyst Rating
Based on
2
analysts
Buy
Current Rating
1.650
Target Price
+58.65%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Hyperfine Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Hyperfine Inc Info
Hyperfine, Inc. is a health technology company. The Company is engaged in providing patient care globally through artificial intelligence (AI)-powered portable ultra-low-field (ULF) magnetic resonance (MR) brain imaging. Its Swoop Portable MR Imaging System (Swoop system) produces images at a lower magnetic field strength than conventional magnetic resonance imaging (MRI) scanners. Its Swoop system is designed to transform brain MR for the patient, the clinician and the provider, enabling a highly differentiated experience for patients, timely imaging for clinicians, and favorable economics for hospital administrators. The Swoop system is a portable ULF MRI device for producing images that display the internal structures of the head where full diagnostic examination is not clinically practical. The Swoop system is FDA-cleared for brain imaging of patients of all ages. The Swoop system is commercially available in a select number of international markets.
Ticker SymbolHYPR
CompanyHyperfine Inc
CEOSainz (Maria Degois)
Websitehttps://hyperfinemri.com/
Related Instruments
+2.98%
+0.07%
+1.60%
+2.48%
+0.31%
-1.14%
-0.05%
-2.35%
-1.78%
+2.65%
+2.59%
+2.03%
+2.01%
+2.38%
+1.74%
+0.16%
+0.78%
+1.72%
+0.59%
-2.02%Popular Symbols
278.120
+2.210 (+0.80%)
185.410
+13.530 (+7.87%)
68064.250
-1905.880 (-2.72%)
282.580
+22.390 (+8.61%)
2017.940
-33.790 (-1.65%)
411.110
+13.900 (+3.50%)
4952.980
+142.360 (+2.96%)
63.303
+0.206 (+0.33%)
1.182
+0.004 (+0.35%)
157.098
+0.057 (+0.04%)
